Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Determination of Interference During In Vitro Pyrogen Detection: Development and Characterization of a Cell-Based Assay.

Palma L, Rossetti F, Dominici S, Buondelmonte C, Rocchi MB, Rizzardi GP, Vallanti G, Magnani M.

Assay Drug Dev Technol. 2017 Feb/Mar;15(2):64-76. doi: 10.1089/adt.2016.758. Epub 2016 Dec 20.

PMID:
27996302
2.

Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories.

Gaipa G, Introna M, Golay J, Nolli ML, Vallanti G, Parati E, Giordano R, Romagnoli L, Melazzini M, Biondi A, Biagi E.

Cytotherapy. 2016 Apr;18(4):481-6. doi: 10.1016/j.jcyt.2016.01.002.

PMID:
26971677
3.

Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, Baldoli C, Martino S, Calabria A, Canale S, Benedicenti F, Vallanti G, Biasco L, Leo S, Kabbara N, Zanetti G, Rizzo WB, Mehta NA, Cicalese MP, Casiraghi M, Boelens JJ, Del Carro U, Dow DJ, Schmidt M, Assanelli A, Neduva V, Di Serio C, Stupka E, Gardner J, von Kalle C, Bordignon C, Ciceri F, Rovelli A, Roncarolo MG, Aiuti A, Sessa M, Naldini L.

Science. 2013 Aug 23;341(6148):1233158. doi: 10.1126/science.1233158. Epub 2013 Jul 11.

4.

Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.

Merten OW, Charrier S, Laroudie N, Fauchille S, Dugué C, Jenny C, Audit M, Zanta-Boussif MA, Chautard H, Radrizzani M, Vallanti G, Naldini L, Noguiez-Hellin P, Galy A.

Hum Gene Ther. 2011 Mar;22(3):343-56. doi: 10.1089/hum.2010.060. Epub 2011 Mar 7.

PMID:
21043787
5.
6.

Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.

Porcellini S, Vallanti G, Nozza S, Poli G, Lazzarin A, Tambussi G, Siccardi AG, Grassi F.

AIDS. 2003 Jul 25;17(11):1621-30.

PMID:
12853744
7.

Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages.

Fantuzzi L, Spadaro F, Vallanti G, Canini I, Ramoni C, Vicenzi E, Belardelli F, Poli G, Gessani S.

Blood. 2003 Oct 1;102(7):2334-7. Epub 2003 Jun 12.

8.

Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells.

Vicenzi E, Panina-Bodignon P, Vallanti G, Di Lucia P, Poli G.

J Leukoc Biol. 2002 Nov;72(5):913-20.

PMID:
12429712
9.

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

Tambussi G, Ghezzi S, Nozza S, Vallanti G, Magenta L, Guffanti M, Brambilla A, Vicenzi E, Carrera P, Racca S, Soldini L, Gianotti N, Murone M, Veglia F, Poli G, Lazzarin A.

J Infect Dis. 2001 May 15;183(10):1476-84. Epub 2001 Apr 13.

PMID:
11319683
10.

The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.

Alfano M, Vallanti G, Biswas P, Bovolenta C, Vicenzi E, Mantelli B, Pushkarsky T, Rappuoli R, Lazzarin A, Bukrinsky M, Poli G.

J Immunol. 2001 Feb 1;166(3):1863-70.

11.

Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4.

Biswas P, Mantelli B, Delfanti F, Cota M, Vallanti G, de Filippi C, Mengozzi M, Vicenzi E, Lazzarin A, Poli G.

Cytokine. 2001 Jan 7;13(1):55-59.

PMID:
11145843
12.

Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate.

Fraternale A, Casabianca A, Tonelli A, Vallanti G, Chiarantini L, Brandi G, Celeste AG, Magnani M.

J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):209-20.

PMID:
10839656
13.

Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat.

Ghezzi S, Noonan DM, Aluigi MG, Vallanti G, Cota M, Benelli R, Morini M, Reeves JD, Vicenzi E, Poli G, Albini A.

Biochem Biophys Res Commun. 2000 Apr 21;270(3):992-6.

PMID:
10772939
14.

Immunologic reconstitution by interleukin-2: facts and open questions.

Vallanti G, Bovolenta C, Brambilla A, Tambussi G, Lazzarin A, Vicenzi E, Poli G.

J Biol Regul Homeost Agents. 2000 Jan-Mar;14(1):41-4. Review.

PMID:
10763892
15.

Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.

Rossi L, Serafini S, Schiavano GF, Casabianca A, Vallanti G, Chiarantini L, Magnani M.

Biochem J. 1999 Dec 15;344 Pt 3:915-20.

16.
17.

Role of macrophage protection in the development of murine AIDS.

Fraternale A, Tonelli A, Casabianca A, Vallanti G, Chiarantini L, Schiavano GF, Benatti U, De Flora A, Magnani M.

J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):81-9.

PMID:
10360798
18.

Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS.

Casabianca A, Vallanti G, Magnani M.

J Clin Microbiol. 1998 Aug;36(8):2371-4.

Supplemental Content

Loading ...
Support Center